US Bancorp’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

US Bancorp’s Portfolio FMTX Stock Details FMTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-3,535	Closed	-$71K	–	4352
2022 Q3	$71K	Buy	3,535 +3,355	+1,864%	+$44.2K	﹤0.01%	2351
2022 Q2	$1K	Sell	180 -4,161	-96%	-$29.2K	﹤0.01%	4050
2022 Q1	$40K	Buy	4,341 +3,206	+282%	+$34.1K	﹤0.01%	2739
2021 Q4	$16K	Buy	1,135 +136	+14%	+$2.35K	﹤0.01%	3248
2021 Q3	$23K	Buy	+999	New	+$23.6K	﹤0.01%	3069

US Bancorp's FMTX Position: Q4 2022 in Review

US Bancorp sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q4 2022, closing a stake of 3,535 shares — an estimated $71K sold.

US Bancorp first reported a position in FMTX in Q3 2021 and held it in 5 quarters. The position peaked at $71K in Q3 2022. 0 funds tracked by Wall St. Rank hold FMTX as of Q4 2022.

US Bancorp reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
US Bancorp sold 3,535 Forma Therapeutics Holdings, Inc. Common Stock shares in Q4 2022, an estimated $71K.
US Bancorp first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q3 2021 and held it in 5 quarters.
US Bancorp's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $71K in Q3 2022.
0 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q4 2022.

Based on US Bancorp's 13F filing for Q4 2022, filed 13 Feb 2023.